Medicare Enrolled

Dr. Praveen Sivakumaran, MD

Hematology & Oncology · Lawrenceville, GA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
631 PROFESSIONAL DR STE 450, Lawrenceville, GA 30046
7709638030
In practice since 2007 (19 years)
NPI: 1023226081 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Sivakumaran from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sivakumaran? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Sivakumaran

Dr. Praveen Sivakumaran is a hematology & oncology specialist in Lawrenceville, GA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Sivakumaran performed 915 Medicare services across 405 unique beneficiaries.

Between the years covered by Open Payments, Dr. Sivakumaran received a total of $3,339 from 38 pharmaceutical and/or device companies across 161 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Sivakumaran is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 38% volume in GA $3,339 industry payments

Medicare Practice Summary

Medicare Utilization ↗
915
Medicare services
Top 38% in GA for hematology & oncology
405
Unique beneficiaries
$71
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~48 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
379 $70 $392
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
162 $45 $276
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
132 $110 $544
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
68 $60 $210
Prolonged office E/M service, first 15 minutes
This code is used for additional time spent by a physician beyond the maximum required time of a primary office or outpatient evaluation and management service. It is billed in 15-minute increments based on total time spent on the date of the primary service.
56 $24 $94
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
36 $94 $301
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
28 $136 $588
Office visit for established patient
An office visit for an existing patient that may not require the healthcare professional to be present.
20 $7 $69
New patient office visit, complex (60-74 min) 19 $129 $669
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
15 $105 $507
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$3,339
Total received (2018-2024)
Avg $477/year across 7 years
Bottom 49% in GA for hematology & oncology
38
Companies
161
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,981 (89.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$358 (10.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,461
2023
$1,110
2022
$272
2021
$148
2020
$139
2019
$143
2018
$65

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$333
Exelixis Inc.
$121
Genentech USA, Inc.
$113
ABBVIE INC.
$104
Janssen Biotech, Inc.
$81
Daiichi Sankyo Inc.
$59
AstraZeneca Pharmaceuticals LP
$59
Dendreon Pharmaceuticals LLC
$52
GlaxoSmithKline, LLC.
$51
Celgene Corporation
$49
Merck Sharp & Dohme LLC
$48
Incyte Corporation
$46
GENZYME CORPORATION
$44
Astellas Pharma US Inc
$38
Regeneron Healthcare Solutions, Inc.
$28
Ipsen Biopharmaceuticals, Inc
$27
ARRAY BIOPHARMA INC
$26
TerSera Therapeutics LLC
$24
Stemline Therapeutics Inc.
$23
Deciphera Pharmaceuticals Inc.
$22
BeiGene USA, Inc.
$22
PUMA BIOTECHNOLOGY, INC.
$22
Novartis Pharmaceuticals Corporation
$22
E.R. Squibb & Sons, L.L.C.
$17
ImmunoGen, Inc.
$16
Gilead Sciences, Inc.
$16
Top 3 companies account for 38.8% of 2024 payments
All-time payments by company (2018-2024) ›
PFIZER INC.
$448
Seagen Inc.
$394
Genentech USA, Inc.
$243
Celgene Corporation
$174
Janssen Biotech, Inc.
$159
Exelixis Inc.
$137
AstraZeneca Pharmaceuticals LP
$129
Seattle Genetics, Inc.
$125
GlaxoSmithKline, LLC.
$123
ABBVIE INC.
$104
Novartis Pharmaceuticals Corporation
$103
Incyte Corporation
$83
Regeneron Healthcare Solutions, Inc.
$83
Astellas Pharma US Inc
$78
GENZYME CORPORATION
$62
Daiichi Sankyo Inc.
$59
Merck Sharp & Dohme Corporation
$55
Amgen Inc.
$53
Dendreon Pharmaceuticals LLC
$52
Gilead Sciences, Inc.
$52
Lilly USA, LLC
$51
PUMA BIOTECHNOLOGY, INC.
$51
Merck Sharp & Dohme LLC
$48
Ipsen Biopharmaceuticals, Inc
$48
Pharmacyclics LLC, An AbbVie Company
$47
Terumo Medical Corporation
$46
ARRAY BIOPHARMA INC
$44
E.R. Squibb & Sons, L.L.C.
$44
Deciphera Pharmaceuticals Inc.
$38
Mirati Therapeutics, Inc.
$32
CTI BioPharma Corp.
$32
Pharmacyclics LLC, an AbbVie Company
$26
TerSera Therapeutics LLC
$24
Stemline Therapeutics Inc.
$23
BeiGene USA, Inc.
$22
ImmunoGen, Inc.
$16
Bayer HealthCare Pharmaceuticals Inc.
$16
Kite Pharma, Inc.
$15
Top 3 companies account for 32.5% of all-time payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AZUR CX DETACHABLE · Alecensa · BESPONSA · BOSULIF · BRAFTOVI · BRUKINSA · CABOMETYX · CALQUENCE · Columvi · DARZALEX · ELAHERE · ELREXFIO · ENHERTU · EPKINLY · Enhertu · Fabhalta · Gazyva · IBRANCE · IMBRUVICA · IMFINZI · INLYTA · Itovebi · JAKAFI · JEMPERLI · KEYTRUDA · KRAZATI · Kyprolis · LIBTAYO · LORBRENA · MONJUVI · NERLYNX · Nplate · OJJAARA · OPDIVO · OPDUALAG · OXBRYTA · Onivyde · Orserdu · PADCEV · PROMACTA · PROVENGE · Padcev · Phesgo · Polivy · Pomalyst · QINLOCK · RYBREVANT · Revlimid · SARCLISA · SCEMBLIX · SHINGRIX · Stivarga · TAGRISSO · TALVEY · TECENTRIQ · TIVDAK · TUKYSA · VENCLEXTA · VERZENIO · Venclexta · Vonjo · Xtandi · Yescarta · Zoladex
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (89%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a hematology & oncology specialist in Lawrenceville?
Compare hematology & oncology specialists in the Lawrenceville area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists within 10 mi
113
Per 100K population
11.7
County median income
$84,823
Nearest hospital
SUMMITRIDGE CENTER- PSYCHIATRY & ADDICTIVE MED
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Sivakumaran is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Sivakumaran experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Sivakumaran performed 379 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sivakumaran receive payments from pharmaceutical companies?
Yes. Dr. Sivakumaran received a total of $3,339 from 38 companies across 161 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sivakumaran's costs compare to other hematology & oncology specialists in Lawrenceville?
Dr. Sivakumaran's average Medicare payment per service is $71. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sivakumaran) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →